Camber Pharma Launches Generic Klor-Con®

Piscataway, NJ, July 6, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Potassium Chloride ER Tablets to their current portfolio, which is the generic version of Klor-Con®
Potassium Chloride ER Tablets are used to prevent or to treat low blood levels of potassium (hypokalemia).
Potassium Chloride ER Tablets from Camber are available in (750 mg) 10 mEq K and (1500 mg) 20 mEq K strengths. Both strengths are available in 100 and 500 count bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025